AKT1 and polycystic ovary syndrome: A growing body of evidence has demonstrated that the aberrant PI3K/AKT pathway in patients with PCOS results in reduced translocation of glucose transporter 4 (GLUT4) from adipocyte and endometrial cells, thus impairing glucose uptake.